A new class of neurosteroids: steroid phosphodiesters (SPEDS)

Active Project Grant Awarded Last action

Award ID
HT94252510097
Recipient
Awarding agency
Obligated
$316,250

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 88% complete
Place of performance
Kannapolis, NC 28081, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The U.S. Defense Health Agency awarded a $316,250 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Coddle Creek Capital, LLC (UEI: S45DEW7HD1T8) located in Kannapolis, NC. The grant, with a performance period from February 1, 2025 to January 31, 2027, will support research on a new class of neurosteroids known as steroid phosphodiesters (SPEDs). The overall goal of this research is to transform healthcare for military service members, veterans, and the broader public through innovative and impactful medical solutions. The research will involve advanced biomedical investigations spanning basic, applied, and translational research disciplines.

Quick answers

Who received award HT94252510097?

HT94252510097 was awarded to Coddle Creek Capital, LLC by Defense Health Agency (Department of Defense) on February 1, 2025.

How much is award HT94252510097 worth?

$316,250 has been obligated on HT94252510097.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login